Status:
COMPLETED
Preferences of Patients Treated With Oral Cancer Drugs and Informal Caregivers for Pharmaceutical Consultation in Hospital
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Conditions:
Preference, Patient
Pharmacist-Patient Relations
Eligibility:
All Genders
18+ years
Brief Summary
To ensure the safe use of oral anticancer drugs, oncology pharmacy consultations (OPCs) have been established in France. Their goal is to provide the patient with the means to identify, prevent and li...
Detailed Description
To ensure the safe use of oral anticancer drugs, oncology pharmacy consultations (OPCs) have been established in France. Their goal is to provide the patient with the means to identify, prevent and li...
Eligibility Criteria
Inclusion
- of patients:
- Main inclusion Criteria:
- Patients with lung, prostate breast, prostate or renal cancer;
- Patients with oral cancer drugs;
- Patients accepted to take par in pharmaceutical consultation in hospital.
Exclusion
Key Trial Info
Start Date :
August 10 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 4 2025
Estimated Enrollment :
167 Patients enrolled
Trial Details
Trial ID
NCT05970471
Start Date
August 10 2023
End Date
December 4 2025
Last Update
December 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Besançon
Besançon, France, 25030